HFF
CADL icon

Halter Ferguson Financial’s Candel Therapeutics CADL Stock Holding History

Halter Ferguson Financial’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.96M Sell
772,461
-131,590
-15% -$994K 1.29% 11
2026
Q1 		$4.43M Buy
904,051
+155,996
+21% +$849K 0.97% 13
2025
Q4 		$4.23M Buy
748,055
+50,051
+7% +$269K 0.93% 14
2025
Q3 		$3.56M Sell
698,004
-78,512
-10% -$454K 0.81% 12
2025
Q2 		$3.93M Buy
776,516
+83,363
+12% +$429K 1.37% 10
2025
Q1 		$3.92M Buy
693,153
+11,819
+2% +$96.6K 2% 7
2024
Q4 		$5.91M Buy
681,334
+376,795
+124% +$2.23M 2.42% 7
2024
Q3 		$2.11M Buy
+304,539
New +$1.89M 1.12% 14

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Halter Ferguson Financial's CADL Position: Q2 2026 in Review

Halter Ferguson Financial reduced its Candel Therapeutics (CADL) stake by 15% in Q2 2026, selling an estimated $994K and leaving 772,461 shares worth $7.96M. The position accounts for 1.29% of the portfolio, ranked #11.

Halter Ferguson Financial first reported a position in CADL in Q3 2024 and has held it in 8 quarters since. 138 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Halter Ferguson Financial held 772,461 shares of Candel Therapeutics worth $7.96M as of Q2 2026.
  • Halter Ferguson Financial sold 131,590 Candel Therapeutics shares in Q2 2026, an estimated $994K.
  • Candel Therapeutics made up 1.29% of Halter Ferguson Financial's portfolio in Q2 2026, its #11 holding.
  • Halter Ferguson Financial first reported a position in Candel Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 138 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Halter Ferguson Financial's 13F filing for Q2 2026, filed 3 Aug 2026.